New Gene Therapy Approach to Treating GA and Dry AMD
December 5, 2011
Submit Comments
Dr. Elias Reichel, of Tufts University School of Medicine and a founder of Hemera Biosciences, Inc., of Boston, MA, presented a new approach to treating geographic atrophy and other dry forms of age-related macular degeneration at the recent AAO 2011 Retina SubSpecialty Day Meeting. His paper was based on the research being done by Hemera Biosciences on HMR59, a naturally occurring protein that protects retinal cells from damage by MAC (Membrane Attack Complex), that can be delivered for long-lasting activity via a gene therapy approach.
HMR59 was developed at Tufts University and subsequently licensed to Hermera Biosciences.
To read more, please follow this link.
Print this post
Filed in Industry News, Macular Degeneration, NeuroOphthalmology, New Technologies, Research, Retina, Stem Cell Therapies
Comments
Jump down to form below to submit your own comments
